Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses
申请人:SANKYO COMPANY LIMITED
公开号:EP0790235A1
公开(公告)日:1997-08-20
Compounds of formula (I):
[in which: R1 represents a saturated heterocyclic group attached to the bond or group represented by A through a ring carbon atom; R2a, R2b, R2c, R3a, R3b, R3c and R3d are hydrogen or various other groups or atoms; and A represents a single bond or an alkylene group having from 1 to 6 carbon atoms] are serotonin 2 receptor antagonists and have the ability to inhibit the activity of squalene synthase. They can not only prevent and inhibit the development and progression of arteriosclerosis but can also inhibit thrombosis in arteriosclerotic lesions and can improve hemodynamics.
式(I)化合物:
其中R1代表通过环碳原子连接到 A 所代表的键或基团上的饱和杂环基团;R2a、R2b、R2c、R3a、R3b、R3c 和 R3d 是氢或各种其他基团或原子;A 代表单键或具有 1 至 6 个碳原子的亚烷基]是血清素 2 受体拮抗剂,具有抑制角鲨烯合成酶活性的能力。它们不仅能预防和抑制动脉硬化的发生和发展,还能抑制动脉硬化病变部位的血栓形成,并能改善血液动力学。